Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Hillert

Showing results (1-10 of 305) with videos related to

Pageof 31
Sort By:
Results and Problems in Cell Differentiation|July 8, 2009
The genetics of multiple sclerosisJan Hillert
Clinical Neurology and Neurosurgery|January 18, 2006
Multiple sclerosis: postlinkage geneticsJan Hillert
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2013
In the coming year we should abandon interferons and glatiramer acetate as first line therapy for MS: noJan Hillert
Nature Reviews. Neurology|February 28, 2020
Socioeconomic status and multiple sclerosis outcomeJan Hillert
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2018
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis - YesFredrik Piehl, Jan Hillert
The Lancet. Neurology|May 26, 2004
The telltale scan: APOE epsilon4 in multiple sclerosisThomas Masterman, Jan Hillert
Current Opinion in Neurology|May 3, 2008
The genetics of multiple sclerosis and its experimental modelsTomas Olsson, Jan Hillert
Journal of Neurology|April 9, 2008
EditorialJan Hillert, Per Soelberg Sørensen
BMC Medicine|June 2, 2016
The importance of collecting structured clinical information on multiple sclerosisTjalf Ziemssen, Jan Hillert, Helmut Butzkueven
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2016
Clinical course of multiple sclerosis: A nationwide cohort studyAli Manouchehrinia, Omid Beiki, Jan Hillert
Pageof 31

Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Results and Problems in Cell Differentiation|July 8, 2009
The genetics of multiple sclerosisJan Hillert
Clinical Neurology and Neurosurgery|January 18, 2006
Multiple sclerosis: postlinkage geneticsJan Hillert
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2013
In the coming year we should abandon interferons and glatiramer acetate as first line therapy for MS: noJan Hillert
Nature Reviews. Neurology|February 28, 2020
Socioeconomic status and multiple sclerosis outcomeJan Hillert
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2018
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis - YesFredrik Piehl, Jan Hillert
The Lancet. Neurology|May 26, 2004
The telltale scan: APOE epsilon4 in multiple sclerosisThomas Masterman, Jan Hillert
Current Opinion in Neurology|May 3, 2008
The genetics of multiple sclerosis and its experimental modelsTomas Olsson, Jan Hillert
Journal of Neurology|April 9, 2008
EditorialJan Hillert, Per Soelberg Sørensen
BMC Medicine|June 2, 2016
The importance of collecting structured clinical information on multiple sclerosisTjalf Ziemssen, Jan Hillert, Helmut Butzkueven
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2016
Clinical course of multiple sclerosis: A nationwide cohort studyAli Manouchehrinia, Omid Beiki, Jan Hillert
Pageof 31